Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07021040 · ClinicalTrials.gov registry record · NA

Olfactory Biopsies

A NA study of Alzheimer Disease and Smell Loss, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
125
Enrollment target
1
Study location

NCT07021040 is a NA study of Alzheimer Disease and Smell Loss that is actively recruiting participants, run by Duke University. The registered enrollment target is 125 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07021040, a NA study of Alzheimer Disease and Smell Loss, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
125 participants
Enrollment target
1
Study location

Study Summary

This research study aims to investigate the function of the olfactory lining in the nasal cavity and its potential alterations in both healthy and diseased conditions. The olfactory lining is involved in the sense of smell. The purpose of this study is to collect tissue from the nasal cavity.

Interventions

  • DIAGNOSTIC_TEST olfactory testing
  • OTHER Odor stimulation
  • PROCEDURE Olfactory biopsy

Study Locations (1)

North Carolina

  • Duke University Health Center - Durham

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2025-01-06
Est. Completion 2028-12-31
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT07021040

The ClinicalTrials.gov registry entry for NCT07021040 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (95% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 3 interventions - of which olfactory testing is the first listed.

NCT07021040 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT07021040 about?

NCT07021040 is a clinical study titled "Olfactory Biopsies". This research study aims to investigate the function of the olfactory lining in the nasal cavity and its potential alterations in both healthy and diseased conditions. The olfactory lining is involved in the sense of smell. The purpose of this study is to collect tissue from the nasal cavity.

What is the current status of trial NCT07021040?

This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2025-01-06. Estimated completion is 2028-12-31.

What conditions does trial NCT07021040 study?

This clinical trial studies the following conditions: Alzheimer Disease, Smell Loss, Smell Dysfunction.

What interventions are being tested in trial NCT07021040?

The interventions under investigation include: olfactory testing (DIAGNOSTIC_TEST), Odor stimulation (OTHER), Olfactory biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT07021040?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07021040 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.